Jacobs Levy Equity Management’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-767,135
| Closed | -$7.21M | – | 1142 |
|
2020
Q3 | $7.21M | Sell |
767,135
-28,476
| -4% | -$268K | 0.07% | 270 |
|
2020
Q2 | $6.09M | Sell |
795,611
-679
| -0.1% | -$5.19K | 0.07% | 300 |
|
2020
Q1 | $4.92M | Buy |
796,290
+68,903
| +9% | +$426K | 0.06% | 296 |
|
2019
Q4 | $8.85M | Buy |
727,387
+213,067
| +41% | +$2.59M | 0.09% | 268 |
|
2019
Q3 | $5.94M | Buy |
514,320
+66,605
| +15% | +$769K | 0.07% | 306 |
|
2019
Q2 | $4.47M | Buy |
447,715
+179,310
| +67% | +$1.79M | 0.06% | 369 |
|
2019
Q1 | $3.46M | Buy |
268,405
+206,972
| +337% | +$2.67M | 0.05% | 399 |
|
2018
Q4 | $933K | Buy |
61,433
+32,633
| +113% | +$496K | 0.02% | 608 |
|
2018
Q3 | $576K | Sell |
28,800
-85,360
| -75% | -$1.71M | 0.01% | 750 |
|
2018
Q2 | $2.23M | Buy |
114,160
+73,560
| +181% | +$1.43M | 0.04% | 485 |
|
2018
Q1 | $818K | Buy |
+40,600
| New | +$818K | 0.01% | 679 |
|
2015
Q1 | – | Sell |
-8,200
| Closed | -$349K | – | 919 |
|
2014
Q4 | $349K | Buy |
+8,200
| New | +$349K | 0.01% | 657 |
|
2014
Q2 | – | Sell |
-52,241
| Closed | -$1.01M | – | 969 |
|
2014
Q1 | $1.01M | Sell |
52,241
-20,800
| -28% | -$403K | 0.02% | 535 |
|
2013
Q4 | $1.77M | Buy |
73,041
+45,281
| +163% | +$1.1M | 0.03% | 452 |
|
2013
Q3 | $596K | Sell |
27,760
-11,000
| -28% | -$236K | 0.01% | 647 |
|
2013
Q2 | $862K | Buy |
+38,760
| New | +$862K | 0.02% | 604 |
|